Risk Prediction for Progression of Macular Degeneration: 10 Common and Rare Genetic Variants, Demographic, Environmental, and Macular Covariates.
about
Genetics and age-related macular degeneration: a practical review for the clinicianRegulation of signaling events involved in the pathophysiology of neovascular AMDThe Application of Genetic Risk Scores in Age-Related Macular Degeneration: A ReviewCOL8A1 rs13095226 polymorphism shows no association with neovascular age-related macular degeneration or polypoidal choroidal vasculopathy in Chinese subjects.Genetics of Unilateral and Bilateral Age-Related Macular Degeneration Severity Stages.Mapping rare, deleterious mutations in Factor H: Association with early onset, drusen burden, and lower antigenic levels in familial AMD.Evaluation of 10 AMD Associated Polymorphisms as a Cause of Choroidal Neovascularization in Highly Myopic EyesThy-1 Regulates VEGF-Mediated Choroidal Endothelial Cell Activation and Migration: Implications in Neovascular Age-Related Macular Degeneration.Adherence to a Mediterranean diet, genetic susceptibility, and progression to advanced macular degeneration: a prospective cohort study.Dietary folate, B vitamins, genetic susceptibility and progression to advanced nonexudative age-related macular degeneration with geographic atrophy: a prospective cohort studyInfluence of CFH, HTRA1 and ARMS2 polymorphisms in the response to intravitreal ranibizumab treatment for wet age-related macular degeneration in a Spanish population.Complement component C3 - The "Swiss Army Knife" of innate immunity and host defenseProtective coding variants in CFH and PELI3 and a variant near CTRB1 are associated with age-related macular degeneration†.Histopathological Insights Into Choroidal Vascular Loss in Clinically Documented Cases of Age-Related Macular Degeneration.ARMS2 variants may predict the 3-year outcome of photodynamic therapy for wet age-related macular degeneration.Pharmacogenetics of Complement Factor H Y402H Polymorphism and Treatment of Neovascular AMD with Anti-VEGF Agents: A Meta-Analysis.Macular Degeneration Epidemiology: Nature-Nurture, Lifestyle Factors, Genetic Risk, and Gene-Environment Interactions - The Weisenfeld Award Lecture.Genetics and genetic testing for age-related macular degeneration.Genome-wide Analysis of Disease Progression in Age-related Macular Degeneration.How Do Patients Respond to Genetic Testing for Age-related Macular Degeneration?Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis.Exploring the Use of Molecular Biomarkers for Precision Medicine in Age-Related Macular Degeneration.
P2860
Q26738526-A9B3B12A-A1EE-4C40-A3AC-C74A4DE16D1FQ26751293-CC7889E5-4826-461A-8673-F5D6B7390031Q26766721-E357FB5F-A9B3-4FCB-8790-2369A234C1EFQ35855286-EB17EFD7-2B73-4DF8-8159-E34EE4E93B56Q36039207-775C5AA7-0B2B-449C-AF90-8CB92075F019Q36116190-4C2D316B-2D18-44B7-B7E3-023386244039Q36137281-5F5D7EE9-EA40-4E23-BCB0-07BC4105718DQ36171006-579572CD-1A13-4C62-BC2D-D689C93F9C88Q36223020-EC2F3802-5B4B-4CFC-9E6C-A2862AE3FB81Q36728621-F2D0EABB-2DA7-482E-AA9E-E7C225515A21Q37266897-5441CD8C-1AA6-4C0B-B694-FA3532C31C61Q38558926-59FA0583-E13A-4E84-A288-281886803A50Q40409510-9D8125CA-8361-4B08-8BD3-4CC8B64F3C58Q40570133-EE3D5FE2-D041-479E-9E8F-D97D012EBA87Q41170365-552B5F3C-4D66-4427-8F26-35BCD218D757Q41833477-E882D3F2-8268-48C8-A732-45196F00F4B6Q47149024-DC796EE6-09E3-4832-B597-2F96711AD2ADQ48326680-9C7B3E27-CE94-4E7F-985D-D601089252FEQ49963850-DD9581D3-8F32-4980-901F-992F0551F3E8Q50101100-FDC81E4B-B2A3-48A0-B138-4BE4048CF4B7Q51608120-540F4DFF-5337-470F-88E6-173941CA3671Q52559837-081F7FAB-CE62-42EB-86A2-BA63CF0EB86D
P2860
Risk Prediction for Progression of Macular Degeneration: 10 Common and Rare Genetic Variants, Demographic, Environmental, and Macular Covariates.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Risk Prediction for Progressio ...... ental, and Macular Covariates.
@ast
Risk Prediction for Progressio ...... ental, and Macular Covariates.
@en
type
label
Risk Prediction for Progressio ...... ental, and Macular Covariates.
@ast
Risk Prediction for Progressio ...... ental, and Macular Covariates.
@en
prefLabel
Risk Prediction for Progressio ...... ental, and Macular Covariates.
@ast
Risk Prediction for Progressio ...... ental, and Macular Covariates.
@en
P2093
P2860
P356
P1476
Risk Prediction for Progressio ...... ental, and Macular Covariates.
@en
P2093
Bernard Rosner
Johanna M Seddon
Manlik Kwong
Rachel E Silver
P2860
P304
P356
10.1167/IOVS.14-15841
P407
P577
2015-04-01T00:00:00Z